Adverse events · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Economic outcomes · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraocular inflammation measured by anterior chamber cell and flare 1 week · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraocular inflammation measured by proportion of participants with corneal edema 1 week · people who received phacoemulsification
Summary of findings for NSAIDs plus corticosteroids showed no clear difference in intraocular inflammation measured by proportion of participants with… compared with corticosteroids alone (moderate certainty).
1 finding from 1 review
Incidence of breast hematoma · women undergoing breast surgery
NSAID showed no clear difference in incidence of breast hematoma compared with placebo (low certainty).
1 finding from 1 review
Number of patients with postoperative nausea and vomiting (24 hours postoperatively) · women undergoing breast surgery
NSAID probably leads to lower incidence rate or severity of postoperative nausea, vomiting, or both compared with other analgesic (moderate certainty).
1 finding from 1 review
Bleeding from any location within 90 days · women undergoing breast surgery
It is very uncertain whether NSAID changes bleeding from any location within 90 days compared with other analgesic (very low certainty).
1 finding from 1 review
Other side effects of NSAID use · women undergoing breast surgery
It is very uncertain whether NSAID changes other side effects of NSAID use compared with other analgesic (very low certainty).
1 finding from 1 review
Opioid use within 24 (± 12) hours of surgery · women undergoing breast surgery
1 finding from 1 review
Pain intensity 24 (± 12) hours following surgery · women undergoing breast surgery
1 finding from 1 review
Pain intensity 24 (± 12) hours following surgery · women undergoing breast surgery
1 finding from 1 review
Number of patients with postoperative nausea and vomiting (24 hours postoperatively) · women undergoing breast surgery
NSAID showed no clear difference in incidence rate or severity of postoperative nausea, vomiting, or both compared with placebo (low certainty).
1 finding from 1 review
Bleeding from any location within 90 days · women undergoing breast surgery
NSAID showed no clear difference in bleeding from any location within 90 days compared with placebo (low certainty).
1 finding from 1 review
Blood transfusion · women undergoing breast surgery
It is very uncertain whether NSAID changes need for blood transfusion compared with placebo (very low certainty).
1 finding from 1 review
Other side effects of NSAID use · women undergoing breast surgery
NSAID showed no clear difference in other side effects of NSAID use compared with placebo (low certainty).
1 finding from 1 review
Opioid use within 24 (± 12) hours of surgery · women undergoing breast surgery
1 finding from 1 review
Incidence of breast hematoma · women undergoing breast surgery
It is very uncertain whether NSAID changes incidence of breast hematoma within 90 days of breast surgery compared with other analgesic (very low certainty).
1 finding from 1 review
Pain intensity 24 (± 12) hours following surgery · women undergoing breast surgery
1 finding from 1 review
Resolution at 12 to 24 weeks Quinell Grade (range 0 to 4, resolved disease is grade 0) · adults (> 18 years of age) with trigger finger
NSAID injection showed no clear difference in resolution at 12 to 24 weeks Quinell Grade (range 0 to 4, resolved… compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Persistent moderate to severe symptoms at 12 to 24 weeks · adults (> 18 years of age) with trigger finger
NSAID injection may leads to higher persistent moderate to severe symptoms at 12 to 24 weeks compared with glucocorticoid injection (low certainty).
1 finding from 1 review